Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF vs sucralfate for prevention of radiation proctitis in pelvic radiotherapy
ChiCTR2200055273Phase 3Recruiting
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in radiation proctitis comparing GM-CSF with Sucralfate (2 arms). Primary endpoint: Incidence and severity of radiation proctitis. Started Jan 2022; status: recruiting.
02
Drugs
sargramostimsucralfate
03
Conditions
radiation proctitis
Beyond the preview
Go deeper on ChiCTR2200055273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055273.